PRP Therapy for Hair Loss: What It Is & Does It Work?

What Is PRP (Platelet-Rich Plasma) Therapy?

Platelet-rich plasma therapy is an autologous (derived from the patient's own blood) biological treatment in which a concentrated platelet preparation is injected directly into the scalp at areas of hair thinning. "Autologous" means no foreign substances are introduced — the treatment uses components of your own blood, eliminating the risk of immune rejection or transmission of blood-borne pathogens.

The rationale is based on platelet biology: platelets are the clotting-and-healing cells in blood. When activated, they release a suite of growth factors stored in alpha granules, including:

• VEGF (vascular endothelial growth factor) — stimulates new blood vessel formation (angiogenesis) around follicles
• PDGF (platelet-derived growth factor) — promotes dermal papilla cell proliferation
• EGF (epidermal growth factor) — stimulates keratinocyte proliferation
• IGF-1 (insulin-like growth factor 1) — promotes anagen phase entry and supports follicle survival
• TGF-β (transforming growth factor beta) — complex role; modulates follicle cycling
• FGF (fibroblast growth factor) — supports follicle stem cell activation

The hypothesis — supported by a growing body of clinical trial evidence — is that delivering high concentrations of these growth factors to the dermal papilla (the follicle's control center) reverses the miniaturization of androgenetic alopecia and shifts follicles from telogen into active anagen.

PRP is not FDA-approved as a drug for hair loss. It is a medical procedure and falls under practitioner regulation, not drug regulation.

How the PRP Procedure Works

Step 1: Blood Draw

A standard blood draw — typically 10–60 mL — is taken from a vein in the arm. The volume depends on the provider's protocol and treatment area.

Step 2: Centrifugation

The blood is placed in a centrifuge and spun to separate its components by density:

• Red blood cells (heaviest) settle at the bottom
• Platelet-poor plasma floats at the top
• Platelet-rich plasma — the middle "buffy coat" layer — is harvested

The target platelet concentration is typically 2–7 times the baseline platelet concentration in whole blood, or approximately 1 million platelets per microliter. Whether to activate PRP before injection (using calcium chloride or thrombin to trigger growth factor release) or rely on activation by scalp trauma varies by protocol and is one of the key variables affecting clinical outcomes.

Step 3: Scalp Injection

Using a fine-gauge needle (typically 30G), the PRP is injected intradermally across the thinning scalp at approximately 1 cm intervals. A topical anesthetic cream or local scalp nerve block is typically applied 20–40 minutes beforehand to reduce pain.

The entire procedure takes approximately 45–90 minutes and is performed in a clinic or dermatology office.

Step 4: Initial Course and Maintenance

Most published protocols use an initial course of 3–4 monthly sessions, followed by maintenance sessions every 3–6 months to sustain results. There is no universally agreed maintenance schedule — this is one of the gaps in current evidence.

What the Evidence Shows

The Broadest Meta-Analysis (PubMed, 2025)

The most comprehensive available systematic review (pubmed.ncbi.nlm.nih.gov/40944844) analyzed 43 randomized controlled trials involving 1,877 participants with various forms of alopecia, including androgenetic alopecia (AGA) in both men and women.

Key conclusions:

• Moderate evidence that PRP is safe and effective at improving hair density
• Statistically significant reduction in hair loss versus control groups
• No significant benefit demonstrated for hair thickness — a secondary outcome where results were inconsistent
• Safety profile was favorable across all 43 trials; no serious adverse events attributable to PRP

PRP for Female Hair Loss (PMC, 2024)

A focused meta-analysis of 21 studies in women (PMC11342464) covering androgenetic alopecia, chronic telogen effluvium, and female pattern hair loss found:

• PRP effectively enhances hair density and thickness in women with hair loss
• Effect size varied with dosage, injection duration, and patient ethnicity
• Safety profile was favorable with minimal adverse events
• PRP was characterized as a viable alternative to topical minoxidil, particularly for patients seeking non-pharmacological approaches

PRP vs. Minoxidil (PubMed, 2025)

Nine RCTs involving 451 participants compared PRP directly with topical minoxidil for AGA. The finding: no significant difference in hair density between PRP and minoxidil. This is clinically significant — it positions PRP as an evidence-based alternative in patients who cannot or prefer not to use topical medications.

PRP + Minoxidil Combination (PubMed, 2024)

Six studies including 343 participants examined combining PRP with minoxidil versus either treatment alone. Result: combination PRP + minoxidil produced significantly greater improvement in hair growth than minoxidil or PRP alone — an additive effect not merely attributable to either treatment.

Split-Scalp Controlled Study (PMC, 2017)

An early well-designed split-scalp study (PMC5561716) directly compared PRP injections to saline injections on opposite sides of the same scalp (eliminating inter-individual variation). Hair density and thickness were significantly greater on the PRP-treated side — a strong design that minimizes confounding.

An important caveat from randomized studies: Some split-scalp studies noted that hair density also increased in the saline control group — suggesting that the microtrauma of the injection itself may contribute to hair regrowth by triggering wound-healing responses independent of PRP's growth factors. This is a recognized confounder in PRP research.

The Mechanism in Androgenetic Alopecia Specifically

In androgenetic alopecia, the hair follicle miniaturization process involves dysregulation of the Wnt/β-catenin signaling pathway — the key pathway controlling anagen entry and hair follicle stem cell activation.

PRP's growth factors, particularly PDGF and VEGF, interact with Wnt signaling components, potentially reversing the pathway suppression that DHT induces. Animal studies and in vitro work support this mechanism, though the clinical hierarchy of which growth factor does the most work in human AGA remains incompletely understood.

The Protocol Problem: Why PRP Results Vary

Unlike minoxidil — a single defined molecule at a fixed concentration — PRP is a biological preparation with significant variability:

This variability is the primary reason systematic reviewers consistently note that comparing results across studies is difficult and that predicting individual outcomes from any one protocol is imprecise. When seeking PRP treatment, asking a provider about their specific protocol, platelet concentration targets, and published evidence base for their approach is reasonable.

Who Is PRP Best Suited For?

PRP is most likely to be useful for:

• Androgenetic alopecia (male or female pattern hair loss) at early to moderate stages — the largest evidence base
• Chronic telogen effluvium — some evidence, particularly in women
• Alopecia areata — emerging evidence, used as adjunct to standard treatments
• Patients who cannot tolerate or prefer to avoid pharmacological treatments (minoxidil, spironolactone)
• Patients with early-stage hair loss where follicles are miniaturized but not yet permanently lost
• As combination therapy alongside topical or oral minoxidil for enhanced results

PRP is less likely to help, or is not indicated, in:

• Scarring alopecias (lichen planopilaris, frontal fibrosing alopecia, discoid lupus) — inflammation and fibrosis destroy follicles; PRP cannot regenerate permanently lost follicles
• Severe or end-stage AGA — where most follicles have become permanently vellus or non-functional
• Patients with platelet disorders, active infections, or blood coagulation abnormalities — PRP is contraindicated
• Patients on anticoagulants (warfarin, apixaban) — increased bleeding risk at injection sites; discuss with physician

Side Effects and Safety

PRP has a well-documented safety profile because it uses the patient's own blood. Reported side effects are typically mild and temporary:

Serious adverse events: No serious adverse events — including infection, nerve damage, or allergic reaction — have been consistently reported across 43 RCTs, reflecting the autologous nature of the treatment.

What PRP Cannot Do

PRP is not a substitute for all hair loss treatments:

• It does not block the underlying androgen-mediated miniaturization of AGA. Without addressing androgens (via minoxidil, spironolactone, or finasteride), hair loss progression continues between sessions.
• It does not permanently restore hair — maintenance sessions are required.
• It cannot regenerate follicles that have been permanently destroyed by scarring alopecia.
• Evidence for PRP in alopecia areata is emerging but not yet sufficient to replace established treatments (topical or injectable steroids, JAK inhibitors).

Cost and Accessibility

PRP for hair loss is typically not covered by health insurance in most markets (it is classified as cosmetic). Session costs range from approximately $400 to $1,500 per session, depending on geography and provider setting. An initial course of 3–4 sessions followed by quarterly or semi-annual maintenance represents a significant financial commitment.

When selecting a provider, prioritize board-certified dermatologists or plastic surgeons with documented PRP experience over aesthetic spa settings with less medical oversight. The quality of the centrifuge system and platelet preparation protocol is not standardized across providers.

PRP in Context: Where It Fits in a Hair Loss Treatment Plan

PRP works best not as a standalone treatment but as part of a comprehensive strategy:

1. First-line: Topical minoxidil (5% foam) ± oral minoxidil (under physician supervision)
2. Second-line addition: Spironolactone (in women with androgen excess) or finasteride (in postmenopausal women)
3. Adjunct or alternative: PRP — particularly when pharmacological options are poorly tolerated, are contraindicated (e.g., during the planning phase before resuming treatment after pregnancy), or when patients want to maximize results

For a full comparison of available hair loss treatments for women — including minoxidil, oral minoxidil, spironolactone, and hair transplant — see our hair ingredients and treatments hub.